Home / Health / Blood Pressure Med Recalled Over Contamination Fears
Blood Pressure Med Recalled Over Contamination Fears
6 Dec
Summary
- Thousands of bottles of bisoprolol fumarate and hydrochlorothiazide recalled.
- Tablets possibly cross-contaminated with ezetimibe, a cholesterol drug.
- Recall is classified as Class III, unlikely to cause adverse health consequences.
Glenmark Pharmaceuticals has initiated a recall of multiple lots of bisoprolol fumarate and hydrochlorothiazide tablets, commonly known as Ziac, which are prescribed for hypertension. The recall stems from the potential cross-contamination of these blood pressure medications with ezetimibe, a cholesterol-lowering drug also manufactured by the company. Reserve samples indicated the presence of ezetimibe traces.
The U.S. Food and Drug Administration has categorized this recall as Class III, signifying that exposure to the affected product is unlikely to result in adverse health consequences. The affected medications were manufactured in Madhya Pradesh, India, for Glenmark Pharmaceuticals, Inc., USA. Consumers are advised to check lot numbers and consult pharmacists and prescribers.
While official guidance from Glenmark and the FDA on handling the recalled tablets is pending, general recommendations suggest checking medication details, contacting healthcare providers, and disposing of the affected medication. Bisoprolol/hydrochlorothiazide works by affecting beta-1 receptors, increasing urination, and relaxing blood vessels to lower blood pressure and reduce risks of heart attack and stroke.
